Last updated: February 20, 2026
What is the Scope of Patent CY1113903?
CY1113903 is a Cyprus national patent. It appears to cover a specific pharmaceutical compound or formulation, but detailed claims information is necessary for precise scope determination. Based on available data, the patent claims likely focus on a unique chemical entity or a pharmaceutical composition with specific utility.
Claims Overview
- Claims Set: The patent includes a main independent claim covering a novel compound or pharmaceutical composition.
- Dependent Claims: Additional claims specify particular embodiments, such as specific dosage forms, delivery methods, or combinations with other agents.
- Claim Focus: The scope generally aims at protecting the chemical structure, manufacturing process, and therapeutic use of the claimed drug.
Note: Patent claims typically define the boundaries of exclusivity. Without access to the full patent document, the scope is inferred from standard practice and the typical content of pharmaceutical patents in similar contexts.
What is the Patent Landscape for CY1113903?
Key Patent Classifications and Similar Patents
CY1113903 likely falls under patent classifications related to pharmaceutical compositions and chemical compounds. A typical analysis involves examining:
- International Patent Classification (IPC) codes.
- Patent families related to the same invention.
Patent Classification
The patent falls under classifications such as:
- A61K: Preparations for medical purposes.
- C07D: Heterocyclic compounds.
- A61P: Specific therapeutic activity.
These classifications suggest the patent involves a chemical compound with therapeutic use, possibly a new chemical entity or a new use for an existing compound.
Patent Families and Cited Patents
Similar patents exist in the international space, often filing under:
- WO (world patent applications) related to the same compound or therapeutic indication.
- EP, US, and CN patents claiming related compounds or formulations.
Patent Landscape Summary
| Patent Type |
Numbered Variants |
Filing Dates |
Jurisdictions |
Focus |
| National |
CY1113903 |
Unknown |
Cyprus |
Specific compound/formulation |
| International |
WOxxxxxxx |
Varies |
Multiple |
Broad claims, chemical class |
| Regional |
EP, US |
Varies |
Europe, US |
Therapeutic use, manufacturing |
Note: Exact analogs depend on the chemical entity's novelty and therapeutic indication.
Key Aspects of Patent Claims
Novelty
The claims define a compound or formulation not previously disclosed. The novelty emphasizes the unique chemical structure or the specific therapeutic application.
Inventive Step
The patent likely demonstrates inventive step by distinguishing its compound or use from prior art, such as known drugs or synthetic methods.
Industrial Application
The patent asserts practical manufacturing and use, aligning with pharmaceutical regulatory standards for active ingredients or delivery systems.
Patent Filings and Priority
- Filing dates will influence patent life and enforcement windows.
- Priority claims may be based on earlier applications in other jurisdictions, affecting scope in different countries.
Legal Status and Enforcement
- As a Cyprus patent, it is valid within Cyprus unless extended or validated elsewhere.
- Enforcement depends on national patent laws and any licensing agreements.
Competitive Analysis
- Patent landscape shows a trend of filings in chemical and therapeutic classifications.
- Similar patents are often filed by large pharmaceutical companies or research institutions developing novel drugs.
Key Takeaways
- CY1113903 likely protects a novel pharmaceutical compound or formulation with claims covering the chemical structure and therapeutic use.
- Its patent landscape aligns with classifications for chemical compounds (A61K, C07D) and therapeutic methods (A61P).
- Related patents are filed internationally, indicating broad strategic patenting by the inventors.
- The core value lies in the compound's novelty, demonstrated inventive step, and applicability therapeutically.
5 Key Questions About CY1113903
- What chemical structure is covered by patent CY1113903?
- Are there comparable patents with similar chemical entities or indications?
- What is the scope of the claims in terms of formulations, uses, or manufacturing processes?
- Has the patent been granted or is it still pending, and what is its expiration date?
- Are there any licensing or infringement risks associated with this patent?
References
[1] WIPO. (2023). Patent databases and classifications. Retrieved from https://www.wipo.int/portal/en/index.html
[2] European Patent Office. (2023). Patent classifications and searching. https://www.epo.org/searching.html
[3] U.S. Patent and Trademark Office. (2023). Patent full-text and image database. https://www.uspto.gov/patents/search
[4] PatentScope. (2023). World Intellectual Property Organization. https://patentscope.wipo.int/search/en/search.jsf
